“달서오피⛪️ ∈OPDAL020.컴∋오피달리기 🐏달서마사지🍻달서마사지🌗달서스파🈚️달서OP👦달서아로마🚥달서안마🍇”的搜索结果，显示 331-340 项，共有 14946 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (RAM) plus paclitaxel (+/- pembrolizumab) following induction pembrolizumab (PEM) in patients with advanced gastric and GEJ adenocarcinoma. Pre-myeloid ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objectives for this study are: The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of ...

4. 妙佑医疗国际移植中心- 临床试验

   Rochester, Minn. The purpose of this study is to investigate the value of ultrasound microvessel imaging for evaluation of transplant kidney health.

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Effects of Cognitive Function, Post-op Fatigue and Quality of Life Comparing General vs Regional Anesthesia for Non-eloquent Brain Tumors Resection.

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   以下为当前的临床试验。 ... （仅限开放性研究）. 按位置、状态和其他条件筛选该研究列表。 Effects of Cognitive Function, Post-op ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Rochester, Minn. The purpose of this study is to understand pain outcomes in patients with cancer who have Chemotherapy-Induced Peripheral Neuropathy (CIPN). IL ...